# Biocon Biologics Limited, Bengaluru, India – FDA Inspections

Source: https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d

> Inspection records and compliance data for Biocon Biologics Limited in Bengaluru. 13 FDA inspections on record, 5 Form 483s, last inspected July 26, 2024.

---

## Details

- Name: Biocon Biologics Limited
- FEI Number: 3003981475
- Facility Type: Drug Substance & Drug Product Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: Block No, B1,B2, B3, B5, Q13 Of Q1 And W20 & Unit S18,1st Floor, Block B4, Sez, Plot No.2,3,4&5, Phase Iv, Bommasandra-Jigani Link Road
- City: Bengaluru
- Country Name: India
- Address: Block No, B1,B2, B3, B5, Q13 Of Q1 And W20 & Unit S18,1st Floor, Block B4, Sez, Plot No.2,3,4&5, Phase Iv, Bommasandra-Jigani Link Road, Bengaluru, India
- Country: India

## Related Documents

- [483 - Biocon Biologics Limited - Unknown Date](https://www.keypedia.com/records/483/biocon-biologics-limited/1dff6c9a-dd43-4ecd-bfcd-53b9e68b1d05) — source: FDA, date: Invalid Date
- [483 - Biocon Biologics Limited - Unknown Date](https://www.keypedia.com/records/483/biocon-biologics-limited/34a3f80d-5688-4e63-9006-3751d02f3b25) — source: FDA, date: Invalid Date
- [483 - Biocon Biologics Limited - 2026-04-29](https://www.keypedia.com/records/483/biocon-biologics-limited/6015db2d-3565-46ce-9e68-1046c1e28414) — source: FDA, date: April 29, 2026
- [483 - Biocon Biologics Limited - 2024-07-26](https://www.keypedia.com/records/483/biocon-biologics-limited/edb15a2b-be4c-4cce-a170-6454059f2901) — source: FDA, date: July 26, 2024
- FDA Inspection 1245708 - Biocon Biologics Limited - 2024-07-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2024
- [483 - Biocon Biologics Limited - 2022-08-26](https://www.keypedia.com/records/483/biocon-biologics-limited/6d696c01-1fee-4b41-9f1e-ae5c564a08fa) — source: FDA, date: August 26, 2022
- [483 - Biocon Biologics Limited - 2022-08-19](https://www.keypedia.com/records/483/biocon-biologics-limited/152eb2db-adeb-44c2-883a-bdac69a6cc99) — source: FDA, date: August 19, 2022
- [483 - Biocon Biologics Limited - 2019-09-19](https://www.keypedia.com/records/483/biocon-biologics-limited/81b17a36-3d2a-4a82-a70c-77f6fce4507a) — source: FDA, date: September 19, 2019
- [FDA Inspection 1114628 - Biocon Biologics Limited - 2019-09-19](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/f0524329-4bf4-4ce6-af03-7af699488a5e) — source: FDA, date: September 19, 2019
- [FDA Inspection 1100840 - Biocon Biologics Limited - 2019-08-30](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/bda77216-5fdd-4704-b7c9-90ceecdde4ef) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019
- [483 - Biocon Biologics Limited - 2019-02-15](https://www.keypedia.com/records/483/biocon-biologics-limited/3858f9b9-9837-4adb-9001-eeb4c7a62761) — source: FDA, date: February 15, 2019
- [FDA Inspection 1080031 - Biocon Biologics Limited - 2019-02-15](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/01806310-a16e-45b3-914e-99cd14c2f9da) — source: FDA, date: February 15, 2019
- [483 - Biocon Biologics Limited - 2018-05-01](https://www.keypedia.com/records/483/biocon-biologics-limited/6fa7e974-b5c4-450b-bb8f-8eb76ae4b514) — source: FDA, date: May 1, 2018
- FDA Inspection 1050980 - Biocon Biologics Limited - 2018-05-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 1, 2018
- [483 - Biocon Biologics Limited - 2017-06-03](https://www.keypedia.com/records/483/biocon-biologics-limited/d469f0a6-221d-4b96-a912-d98125df7f1b) — source: FDA, date: June 3, 2017
- [FDA Inspection 1016114 - Biocon Biologics Limited - 2017-06-03](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/7328e444-a60d-4390-b252-256bf9a29dfd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 3, 2017
- [FDA Inspection 1011627 - Biocon Biologics Limited - 2017-04-07](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/0aefbacd-66f3-4b02-a58d-c1baf8deb150) — source: FDA, date: April 7, 2017
- FDA Inspection 948968 - Biocon Biologics Limited - 2015-10-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2015
- FDA Inspection 934266 - Biocon Biologics Limited - 2015-06-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2015
- FDA Inspection 793259 - Biocon Biologics Limited - 2012-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012

## Related Companies

- [Pharmathen International S.A.](https://www.keypedia.com/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198)
- [Eugia SEZ Private Limited](https://www.keypedia.com/companies/eugia-sez-private-limited/c458dd25-5620-40af-93fe-f25936ff47e8)
- [AAA Pharmaceutical, Inc.](https://www.keypedia.com/companies/aaa-pharmaceutical-inc/a4bd33c0-4805-416c-93f2-55e4116cc481)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59)
- [Eugia Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559)
- [Teyro Labs Private Limited](https://www.keypedia.com/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b)
- [Dr. Reddy’s Laboratories Limited](https://www.keypedia.com/companies/dr-reddys-laboratories-limited/19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6)
- [FAMAR HEALTH CARE SERVICES MADRID SA](https://www.keypedia.com/companies/famar-health-care-services-madrid-sa/714d760c-6b6d-4a4b-9b1e-998380c3ba18)
- [LSNE-Leon, SLU](https://www.keypedia.com/companies/lsne-leon-slu/44b5bd66-624e-4c64-8c14-68139ec58183)
- [Stira Pharmaceuticals LLC](https://www.keypedia.com/companies/stira-pharmaceuticals-llc/5e44f5bb-4d18-40fa-b93c-7510e3099999)

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [investigator](https://www.keypedia.com/people/laura-fontan/b27b02a3-9ab1-49df-b2bc-ee936b69d76a)
- [Laurie A. Nelson](https://www.keypedia.com/people/laurie-a-nelson/dbd373d1-ce1f-486c-a932-d93f8f52832d)
- [Ganesh D. Reddy](https://www.keypedia.com/people/ganesh-d-reddy/c5553672-1f1e-431c-be37-4862a203c27d)
